Drug details

Addyi (flibanserin tablets, for oral use)

type of Serotonin 5-HT-Receptor Agonists

Addyi (flibanserin) is a multifunctional serotonin agonist and antagonist (MSAA) indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• fever,
• lightheadedness,
• confusion,
• dizziness,
• blurred vision,
• fainting,
• sweating,
• weakness,
• vomiting
• unusual tiredness,
• unusual drowsiness,
• sleepiness,
• bloating,
• sensation of spinning,
• feeling of constant movement of self or surroundings,
• severe cramping,
• lower abdominal pain, and

The following drugs are related to Addyi, either as a replacement or used together:

• Vyleesi (bremelanotide injection)